Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 644

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 644
---
 adjusted as the stock consideration to be issued as Merger Consideration is subject to adjustment in accordance with the Merger Agreement. The unaudited pro forma condensed combined financial information has been prepared to give pro forma effect with respect to both the reverse share split, as effected on October 18, 2024 for the Kintara Merger, as well as the additional issuance of shares and related transactions surrounding the Merger Consideration in the Mergers for Kineta shareholders.

|                                                      |     | Share Ownership 
 Post-Business   
 Combination     |            |     | Approx. % |       |   |
| TuHURA Biosciences, Inc. existing stockholders(1)(2) |     |                 | 49,100,119 |     |           |  93.4 | % |
| Kineta, Inc. existing public stockholders(3)         |     |                 |  3,476,566 |     |           |   6.6 | % |
| Pro Forma Common Stock                               |     |                 | 52,576,685 |     |           | 100.0 | % |

| (1) | Includes (i) 42,284,525 shares issued and outstanding to TuHURA common stockholders following the Reverse Recapitalization with Kintara, (ii) 297,029 shares underlying the penny warrants issued to underwriters in lieu of cash payment notes, as-converted upon their issuance, and (iii) 6,518,565 estimated shares issued in connection with the Concurrent Investment agreement |

| (2) | Excludes (i) 6,587,057 shares underlying the options issued to TuHURA stockholders, (ii) 7,305,663 shares underlying the warrants issued to TuHURA stockholders (iii) 3,659,967 shares underlying the warrants issued to TuHURA Note holders, and (iv) 1,539,958 shares underlying the CVR Agreement |

| (3) | Includes (i) 2,607,425 shares issued as the “Initial Share Consideration” component of the aggregate merger consideration in the Business Combination and (ii) 869,141 shares issued as the “Kineta Delayed Share Consideration” component of the aggregate merger consideration in the Business Combination for historical Kineta common stockholders based on their pro rata share of Kineta’s historical equity (based on the number of Kineta fully diluted shares held by them)